Renal Cancer
Patient-Reported Outcomes in KEYNOTE-564: Adjuvant Pembrolizumab Versus Placebo for Renal Cell Carcinoma.
August 18, 2023
Diabetes, Obesity, and Pathologic Upstaging in Renal Cell Carcinoma: Results from a large multi-institutional consortium.
August 17, 2023
A genetic basis for cancer sex differences revealed in Xp11 translocation renal cell carcinoma.
August 15, 2023
ExPert ConsEnsus on the management of Advanced clear-cell RenaL celL carcinoma: INDIAn Perspective (PEARL-INDIA).
August 11, 2023
Outcomes of Consolidative Nephrectomy following Primary Immunotherapy in Advanced Renal Cell Carcinoma: A Multicenter Analysis.
August 11, 2023
Assessment of eligibility criteria in renal cell carcinoma trials evaluating systemic therapy.
August 10, 2023
Hereditary Renal Cell Carcinoma: Is Age an Independent Criterion for Genetic Testing? A Large Cohort from a Latin America Referral Center.
August 10, 2023
Demographic Patterns and Clinicopathological Analysis of Sarcomatoid Renal Cell Carcinoma in US Population.
August 9, 2023
Patient-reported Outcome Measurement and Reporting for Patients with Advanced Renal Cell Carcinoma: A Systematic Literature Review.
August 9, 2023
Cellular and Molecular Features of Clear-Cell Renal Cell Carcinoma Tumors - Expert Commentary
August 8, 2023
Creatinine to Cystatin-C Ratio in Renal Cell Carcinoma: A Clinically Pragmatic Prognostic Factor and Sarcopenia Biomarker.
August 8, 2023
Chromophobe renal cell carcinoma.
August 8, 2023